Identification of gene signature for treatment response to guide precision oncology in clear-cell renal cell carcinoma

Clear-cell renal cell carcinoma (ccRCC) is a common therapy resistant disease with aberrant angiogenic and immunosuppressive features. Patients with metastatic disease are treated with targeted therapies based on clinical features: low-risk patients are usually treated with anti-angiogenic drugs and...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Costa, Ninadh M., Cina, Davide, Shrestha, Raunak, Bell, Robert H., Lin, Yen-Yi, Asghari, Hossein, Monjaras-Avila, Cesar U., Kollmannsberger, Christian, Hach, Faraz, Chavez-Munoz, Claudia I., So, Alan I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005147/
https://www.ncbi.nlm.nih.gov/pubmed/32029828
http://dx.doi.org/10.1038/s41598-020-58804-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005147/
https://www.ncbi.nlm.nih.gov/pubmed/32029828
http://dx.doi.org/10.1038/s41598-020-58804-y

Ejemplares similares